Onconova Therapeutics Announces The Presentation Of Preliminary Clinical Data Providing Evidence Of Rigosertib’s Activity In RDEB-associated Squamous Cell Carcinoma

by | Dec 2, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.